Vitamin B12: What This Test Actually Measures

What the Serum B12 Number Actually Represents

The serum B12 test measures total cobalamin dissolved in plasma, combining both the active fraction bound to transcobalamin II (roughly 20 to 30%) and the inactive fraction bound to haptocorrin. Because most circulating B12 is bound to haptocorrin and unavailable to cells, a "normal" serum level can still mask tissue-level deficiency in some patients. Watanabe et al., 2013 reviewed cobalamin transport and confirmed that holotranscobalamin, the active subfraction, is a more sensitive early marker, though it is not yet widely ordered in routine practice.

Why the Total Number Can Mislead

A serum B12 of 250 pg/mL sits inside most laboratory reference intervals, yet a patient with that value and neurological symptoms may have a functionally low supply at the tissue level. The 2015 British Columbia guidelines, cited in a review published at NCBI, note that "serum B12 alone has a sensitivity of only 50 to 80% for identifying deficiency" and recommend adding methylmalonic acid (MMA) when clinical suspicion remains.

The Two Confirmatory Markers

When serum B12 is between 150 and 300 pg/mL, two downstream metabolites become the practical gold standard:

• Methylmalonic acid (MMA): Rises when cobalamin is insufficient for converting methylmalonyl-CoA to succinyl-CoA. A value above 0.4 micromol/L supports functional deficiency. Stabler, 2013 in NEJM confirmed MMA elevates before neurological damage appears.
• Homocysteine: Rises when B12 (and/or folate) cannot drive remethylation. A homocysteine above 15 micromol/L adds weight to a borderline serum B12 result.

Neither marker alone is sufficient, but together they raise diagnostic specificity above 90% per the same NEJM review.

Normal Vitamin B12 Range

Most U.S. Commercial laboratories set the reference interval at 200 to 900 pg/mL (148 to 664 pmol/L), though upper limits vary slightly by assay. The NIH Office of Dietary Supplements B12 fact sheet states that values below 200 pg/mL "generally indicate deficiency," while values between 200 and 300 pg/mL represent a gray zone where confirmatory testing is warranted.

Age and Pregnancy Adjustments

Values drift downward with age even in the absence of dietary change, partly because gastric acid secretion declines and crystalline B12 absorption from fortified foods falls. Pregnant patients require higher circulating levels to support fetal neural-tube closure and myelination; the American College of Obstetricians and Gynecologists recommends adequate cobalamin throughout pregnancy, with deficiency defined at the same threshold but clinical concern starting above 300 pg/mL for this group.

Units Conversion

To convert pg/mL to pmol/L, multiply by 0.7378. A value of 200 pg/mL equals approximately 148 pmol/L. Ordering clinicians should confirm which unit their lab reports.

What a Low Vitamin B12 Means

A result below 200 pg/mL, or a borderline result with elevated MMA or homocysteine, signals inadequate cobalamin at the cellular level. Green et al., 2017 in Annals of Internal Medicine classified the clinical stages of deficiency from early (biochemical only) through late (irreversible neurological damage), emphasizing that treatment must begin before stage 3.

Common Causes

• Dietary insufficiency: Strict vegans and long-term vegetarians are at highest risk because B12 is found almost exclusively in animal-source foods. A 2016 cross-sectional study (NCBI PMC) found deficiency in up to 86.5% of vegans not supplementing.
• Pernicious anemia: Autoimmune destruction of gastric parietal cells eliminates intrinsic factor, making oral absorption impossible regardless of intake. Anti-intrinsic-factor antibodies are positive in roughly 70% of cases per NEJM review data.
• Metformin use: Metformin interferes with calcium-dependent membrane action required for ileal B12-intrinsic-factor complex absorption. The ADA's 2024 Standards of Care (diabetesjournals.org) recommend periodic B12 monitoring in patients on long-term metformin, particularly those with anemia or peripheral neuropathy.
• Gastric surgery: Sleeve gastrectomy and Roux-en-Y gastric bypass remove or bypass the parietal-cell-rich fundus. A meta-analysis of 26 studies in PubMed found B12 deficiency in up to 30% of bypass patients by 12 months post-operatively without supplementation.
• Proton pump inhibitors (PPIs): Long-term PPI use reduces acid-mediated release of B12 from food protein. A Kaiser Permanente cohort study (JAMA, 2013) found a 65% increased risk of B12 deficiency with more than 2 years of daily PPI use.

Symptoms Linked to Deficiency

Low B12 affects two enzyme systems: methionine synthase (needed for DNA synthesis and myelin production) and methylmalonyl-CoA mutase. Neurological symptoms, tingling, proprioception loss, cognitive slowing, may appear before the blood count shows macrocytosis. The NIH ODS fact sheet lists subacute combined degeneration of the spinal cord as the most severe neurological consequence.

What a High Vitamin B12 Means

A serum B12 above 900 pg/mL, especially without recent supplementation, requires investigation. High levels are not simply the harmless result of eating well. Arendt et al., 2016 in JAMA Internal Medicine followed 333,667 Danish patients and found that persistently elevated B12 without supplement use was associated with an increased 1-year risk of cancer, particularly solid tumors and hematological malignancies.

Causes of Elevated Serum B12

• Supplement or injection excess: The most common explanation in an outpatient setting. Oral doses above 2,000 mcg/day regularly drive serum values above 1,000 pg/mL. Dose reduction corrects the level within weeks.
• Liver disease: Hepatocytes store roughly 50 to 90% of total body B12. Hepatitis, cirrhosis, or hepatic metastases release stored cobalamin into circulation, elevating serum levels independently of intake.
• Myeloproliferative disorders: Polycythemia vera and chronic myelogenous leukemia (CML) overproduce haptocorrin, raising total serum B12. Per a review in Blood, haptocorrin-bound B12 can exceed 2,000 pg/mL in active CML.
• Solid tumors: Breast, colon, and gastric cancers have been associated with elevated B12 in observational data, possibly via increased haptocorrin secretion.

A single elevated reading in a patient taking high-dose B12 supplements needs only a repeat test after stopping supplementation for 4 weeks. A persistently elevated level without supplement use warrants a CBC with differential, liver function panel, and clinical review.

How the B12 Test Is Performed

A routine serum B12 requires a standard venous blood draw, no fasting required. The sample is analyzed by competitive immunoassay or electrochemiluminescence immunoassay (ECLIA). Results from most U.S. Labs return within 24 to 72 hours. Intramuscular B12 injections within the prior 48 hours will falsely raise results; patients on injection therapy should ideally be tested just before their next scheduled dose.

Holotranscobalamin as a Preferred Marker

Holotranscobalamin (holoTC), the fraction bound to transcobalamin II, represents the biologically active pool available to cells. Herrmann and Obeid, 2013 published evidence that holoTC below 35 pmol/L identifies deficiency with higher sensitivity than total serum B12. Availability of holoTC testing varies by laboratory. When accessible, it adds precision in borderline cases.

How to Raise a Low Vitamin B12

Correction strategy depends entirely on the cause. Absorption failure and dietary insufficiency require different approaches.

Oral Supplementation

For dietary deficiency without malabsorption, oral cyanocobalamin 1,000 to 2,000 mcg/day is effective because approximately 1% of a large oral dose is absorbed passively, bypassing intrinsic factor. A Cochrane review (cochranelibrary.com) found that high-dose oral B12 was as effective as intramuscular injection for normalizing serum levels and MMA in patients with dietary deficiency, with normalization typically occurring within 90 days.

Intramuscular Injection

Pernicious anemia, post-bariatric patients, or anyone with confirmed malabsorption requires intramuscular or deep subcutaneous hydroxocobalamin. The standard U.K. NHS regimen starts with 1,000 mcg every other day for 2 weeks, then moves to 1,000 mcg every 3 months for maintenance (every 2 months if neurological symptoms are present). The British National Formulary approach aligns with North American practice at most academic centers.

Metformin-Specific Protocol

For patients on metformin who develop B12 depletion, the ADA 2024 Standards of Care suggest three options ordered by clinical severity:

1. Mild depletion (200 to 300 pg/mL, no symptoms): Oral cyanocobalamin 1,000 mcg/day with annual recheck.
2. Moderate depletion (<200 pg/mL, no neurological signs): Oral cyanocobalamin 2,000 mcg/day or monthly IM injection; recheck MMA and homocysteine at 3 months.
3. Symptomatic deficiency (any B12 with neuropathy or cognitive change): IM hydroxocobalamin loading regimen, urgent neurology referral, and reassessment of whether metformin dose can be reduced.

This framework applies regardless of whether the patient is also taking a GLP-1 receptor agonist. STEP-1 (N=1,961) and related semaglutide trials did not identify semaglutide as a B12-depleting agent, so GLP-1 therapy alone does not change the monitoring schedule.

Dietary Sources

For patients who can absorb B12 normally, diet matters. The RDA for adults is 2.4 mcg/day per the NIH ODS. Clams (84 mcg per 3 oz serving), beef liver (70 mcg per 3 oz), and fortified breakfast cereals (up to 6 mcg per serving) are the highest-density sources. Diet alone, however, cannot correct established deficiency quickly enough when neurological symptoms are present.

Who Should Be Tested Routinely

No universal population screening for B12 exists in the USPSTF recommendations as of 2025 (uspstf.org). Targeted testing is appropriate for:

• Adults over 60, given age-related decline in gastric acid and intrinsic factor
• Anyone on metformin for more than 4 years or at doses above 1,500 mg/day
• Patients after bariatric surgery (annual testing recommended by most surgical societies per ASMBS guidelines)
• Vegans and strict vegetarians not taking a B12 supplement
• Patients with unexplained macrocytic anemia, peripheral neuropathy, or cognitive decline
• Anyone on long-term PPI therapy (>2 years of daily use)
• Patients with autoimmune thyroid disease, who have a 40% co-prevalence of pernicious anemia per endocrine.org data

B12 in Specific Clinical Populations

Neurological and Cognitive Impact

Cobalamin is required for myelin synthesis via methionine synthase. Deficiency causes subacute combined degeneration affecting the posterior and lateral columns of the spinal cord. A large observational study in JAMA Neurology found that serum B12 below 250 pg/mL was associated with accelerated cognitive decline in adults over 65, even before anemia appeared.

The Endocrine Society's 2019 clinical practice guideline on micronutrient deficiencies (endocrine.org) states: "Vitamin B12 deficiency should be excluded in any patient presenting with unexplained neurological symptoms, regardless of the serum hemoglobin."

Cardiovascular Risk

Homocysteine elevation from B12 deficiency is an independent cardiovascular risk factor. The American Heart Association recognized elevated homocysteine as a risk marker in a 1999 consensus statement, though intervention trials correcting homocysteine with B vitamins have not consistently reduced clinical cardiac events. The implication: normalizing B12 lowers homocysteine biochemically, but that change alone may not reduce MI risk without addressing other factors.

Pregnancy and Fertility

The neural tube closes by day 28 post-conception, before most women know they are pregnant. Low B12, even without overt deficiency, may impair folate metabolism and raise neural-tube defect risk. The American College of Obstetricians and Gynecologists advises cobalamin assessment in women planning pregnancy who follow plant-based diets or have GI conditions affecting absorption.

How to Interpret Your Result in Context

A single serum B12 number tells part of the story. Clinicians interpreting the result should layer in:

• Symptom history (neuropathy, fatigue, cognitive change)
• Dietary pattern and supplement use
• Current medications (metformin, PPIs, H2 blockers, nitrous oxide exposure)
• GI history (gastric surgery, Crohn disease, celiac disease)
• CBC findings (MCV above 100 fL, hypersegmented neutrophils)

When the serum B12 falls in the 200 to 300 pg/mL range and the clinical picture is ambiguous, order MMA and homocysteine before deciding whether to treat. MMA above 0.4 micromol/L in that context confirms functional deficiency and justifies starting supplementation without waiting for a repeat serum level.